YENOS ANALYTICAL, LLC

Medtech · Private

Ultra-fast nanopore sequencing platform for small RNA biomarker detection in biological fluids, using proprietary osmium-labeling technology

Grants
$907K
3 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Novel Nanopore-based RNA Sequencing using Nucleobase-specific Tags$280,000
Federal grantDepartment of Health and Human Services · Phase I · Profiling miRNAs using a nanopore device and two nucleobase-selective tags$350,000
Federal grantDepartment of Health and Human Services · Phase I · Sequencing microRNAs, with single-base discrimination, using a nanopore device and an Osmium tag.$276,817
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1767Atom Bioworks Inc——
1768LI-COR BIOSCIENCES, INC.——
1769AVIV BIOMEDICAL, INC.——
1770YENOS ANALYTICAL, LLC——
1771River Sonic Solutions LLC——
1772REKOVAR INC.——
1773MEDICAL CARE CORPORATION——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.